GNOM Global X Genomics & Biotechnology ETF Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
19:33
Oct 05
incomesharks
Early on genome narrative, GNOM upside
Maintains a long-term bullish genome/biotech thesis, arguing the sector is undervalued on AI-driven narrative and should be much higher by 2030; frames GNOM as an early-narrative name.
GNOM Global X Genomics & Biotechnology ETF Long — —
14:52
Aug 25
incomesharks
Genome sector with AI could run higher
Author suggests a bullish breakout for the genome ETF, arguing the sector combines biotech with AI and is underappreciated, with significant upside potential by 2030.
GNOM Global X Genomics & Biotechnology ETF Long — —
15:38
Aug 19
incomesharks
AI integration drives long-term genomics sector upside.
Author is bullish on the genomics ETF, arguing the sector is still in its early stages and will benefit significantly from AI integration.
GNOM Global X Genomics & Biotechnology ETF Long — —
Log in to see ideas

About GNOM Investor Commentary

Across the available history and selected sources, Buzzberg tracks GNOM (Global X Genomics & Biotechnology ETF) across 2 sources: 8 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 80% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 10 total trade ideas tracked. Latest voices: incomesharks.